Ulrik Pedersen-Bjergaard
Overview
Explore the profile of Ulrik Pedersen-Bjergaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
1147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fabricius T, Verhulst C, Svensson C, Wienberg M, Duijnhouwer A, Tack C, et al.
Diabetes Obes Metab
. 2025 Mar;
PMID: 40045554
Aims: Cardiovascular disease is the most common complication and cause of death in people with diabetes. Hypoglycaemia is independently associated with the development of cardiovascular complications, including death. The aim...
2.
Olsen M, Jensen S, Rasmussen L, Klarskov C, Lindegaard B, Andersen J, et al.
Diabetes Obes Metab
. 2025 Feb;
PMID: 40000406
Aims: Understanding whether improved glycaemic outcomes from continuous glucose monitoring (CGM) compared to point-of-care (POC) glucose testing apply uniformly to all hospitalised non-intensive care unit (non-ICU) patients with type 2...
3.
Olsen M, Liarakos A, Wilmot E, Dhatariya K, Thabit H, Sanchez-Garcia D, et al.
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39918053
Introduction: Continuous glucose monitoring (CGM) provides real-time glucose data that has revolutionised outpatient diabetes care; however, its impact on inpatient care remains limited, likely due to the lack of standardised...
4.
Olsen M, Klarskov C, Jensen S, Rasmussen L, Lindegaard B, Andersen J, et al.
Diabetes Care
. 2025 Jan;
PMID: 39887698
Objective: The DIATEC trial investigates the glycemic and clinical effects of inpatient continuous glucose monitoring (CGM)-guided insulin titration by diabetes teams. Research Design And Methods: This two-center trial randomized 166...
5.
Nitschke M, Hemmingsen M, Norgaard H, Robak K, Norrevang P, Andersen M, et al.
J Diabetes Sci Technol
. 2025 Jan;
19322968251315184.
PMID: 39862064
No abstract available.
6.
She R, Suvitaival T, Andersen H, Hommel E, Norgaard K, Wojtaszewski J, et al.
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39829147
Introduction: Metabolic responses to glucagon beyond the promotion of endogenous glucose production in type 1 diabetes remains poorly explored. Therefore, we aimed to investigate the metabolic responses to glucagon stimulation...
7.
Nielsen C, Grigonyte-Daraskeviciene M, Olsen M, Moller M, Norgaard K, Perner A, et al.
Intensive Care Med
. 2024 Oct;
50(12):2005-2018.
PMID: 39417874
Purpose: Glycemic control poses a challenge in intensive care unit (ICU) patients and dysglycemia is associated with poor outcomes. Continuous glucose monitoring (CGM) has been successfully implemented in the type...
8.
Sorensen K, Gerds T, Kober L, Fosbol E, Poulsen H, Moller A, et al.
J Diabetes
. 2024 Oct;
16(10):e70000.
PMID: 39364788
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are increasingly being prescribed in drug-naive patients. We aimed to contrast add-on therapy, adherence, and changes in biomarkers, 1 year after treatment initiation...
9.
Divilly P, Martine-Edith G, Zaremba N, Soholm U, Mahmoudi Z, Cigler M, et al.
Diabetes Care
. 2024 Aug;
47(10):1769-1777.
PMID: 39207738
Objective: Use of continuous glucose monitoring (CGM) has led to greater detection of hypoglycemia; the clinical significance of this is not fully understood. The Hypoglycaemia-Measurement, Thresholds and Impacts (Hypo-METRICS) study...
10.
Soholm U, Broadley M, Zaremba N, Divilly P, Baumann P, Mahmoudi Z, et al.
Diabetologia
. 2024 Jul;
67(10):2160-2174.
PMID: 39080044
Aims/hypothesis: The aim of this work was to examine the impact of hypoglycaemia on daily functioning among adults with type 1 diabetes or insulin-treated type 2 diabetes, using the novel...